Chemcon Speciality Chemicals garners Rs 95 crore from 13 anchor investors ahead of IPO

IDFC AMC, Tata AMC and ICICI Prudential also participated in the anchor book bidding

Speciality chemicals manufacturer Chemcon Speciality Chemicals has raised Rs 95.4 crore from 13 anchor investors on September 18 ahead of its public issue opening next week.

"The IPO committee of the company, in consultation with merchant bankers, has finalised allocation of 28,05,880 equity shares to anchor investors at Rs 340 per share, at the higher end of the price band," the company said in a circular filed with the exchanges.

These 13 anchor investors included some prominent names like Abakkus Emerging Opportunities Fund, HSBC Global Investment Funds, Mirae AMC, Kuber India Fund, Ashmore India Opportunities Fund, India Acorn Fund and Aurigin Master Fund. IDFC AMC, Tata AMC, ICICI Prudential also participated in the anchor book.

The initial public offering of the only manufacturer of HMDS in India will open for subscription on September 21 and will close on September 23. The IPO price band has been fixed at Rs 338–340 per equity share.

The company proposes to raise Rs 318 crore via the IPO, which consists of a fresh issue of Rs 165 crore and offer for sale of 45 lakh equity equity shares by promoters.

The speciality chemicals maker will utilise the issue proceeds towards expansion of manufacturing facility, working capital requirement and general corporate purposes.

Comments

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...

SD Solutions

Search This Blog